NCT03589482

Brief Summary

Mechanical ventilation can cause damage by overstretching the lungs, especially when the lungs are collapsed or edematous. Raising ventilator pressures can reduce lung collapse and this can prevent overstretching from mechanical ventilation. It remains uncertain how much pressure (PEEP - positive end-expiratory pressure) should be used on the ventilator and how to identify patients who will benefit from higher ventilator pressures vs. lower ventilator pressures. The investigators are using a unique new imaging technology, electrical impedance tomography (EIT), to study this problem and to determine the safest and most effective ventilator pressure level. The results of this study will inform future trials of higher vs. lower PEEP strategies in mechanically ventilated patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 6, 2018

Completed
3 months until next milestone

First Posted

Study publicly available on registry

July 18, 2018

Completed
8 months until next milestone

Study Start

First participant enrolled

March 1, 2019

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2021

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2021

Completed
Last Updated

November 21, 2023

Status Verified

August 1, 2020

Enrollment Period

2.1 years

First QC Date

April 6, 2018

Last Update Submit

November 20, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Intratidal ventilation heterogeneity

    A measure of variation in the distribution of ventilation throughout the lung as detected by electrical impedance tomography

    Assessed after completion of 3 hours on randomized strategy (EIT vs ExPRESS)

Secondary Outcomes (3)

  • Difference in the optimal PEEP levels identified by several different PEEP titration strategies

    Assessed immediately after completion of decremental PEEP titration procedure

  • Change in ratio of partial pressure of oxygen (PaO2) to inspired fraction of oxygen (FiO2) ratio following a standardized increased in PEEP

    Assessed 10 minutes after step PEEP increase from 6-8 to 16-18 cm H2O

  • Respiratory mechanics (transpulmonary driving pressure)

    Assessed after completing 3 hours on the randomized PEEP strategy (EIT vs ExPRESS)

Study Arms (2)

EIT algorithm

EXPERIMENTAL

Patients randomized to this arm will be ventilated at the PEEP level selected by the EIT algorithm, which selects a PEEP at which both collapse and hyperdistention are minimized.

Device: Electrical Impedance Tomography

ExPRESS algorithm

ACTIVE COMPARATOR

Patients randomized to this arm will be ventilated at the PEEP level selected by the ExPRESS algorithm, which is a method that targets a tidal volume of 6 ml/kg predicted body weight and then titrates PEEP until plateau airway pressure reaches 28 cm H2O.

Other: ExPRESS-derived PEEP level

Interventions

Electrical impedance tomography (EIT) is a new technique that enables real-time visualization of the distribution of ventilation at the bedside. This technique allows clinicians and investigators to immediately determine how applying higher or lower PEEP levels affect stress and strain in the lung. The investigators propose to apply this new technique to test a strategy for finding the optimal level of PEEP that prevents lung injury and improves outcomes in critically ill patients.

EIT algorithm

The ExPRESS algorithm is a traditional approach to selecting PEEP based on respiratory mechanics.

ExPRESS algorithm

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Acute (≤7 days) hypoxemia with PaO2:FiO2 ratio less than or equal to 200 mm Hg
  • Oral endotracheal intubation and mechanical ventilation
  • Bilateral airspace opacities on chest radiograph or CT

You may not qualify if:

  • Contraindication to EIT electrode placement (burns, chest wall bandaging limiting electrode placement)
  • Contraindication to esophageal catheter placement (recent upper GI surgery, actively bleeding esophageal varices)
  • Respiratory failure predominantly due to cardiogenic cause or fluid overload
  • Ongoing hemodynamic instability (requiring 2 vasopressor agents by continuous infusion AND rising vasopressor infusion rate requirements in the previous 8 hours)
  • Ongoing ventilatory instability (P/F \< 70 mm Hg, pH \< 7.2; ventilator driving pressures, PEEP, or FiO2 increasing by more than 25% in previous 30 minutes)
  • Intracranial hypertension (suspected or diagnosed by medical team)
  • Known or suspected pneumothorax recognized within previous 72 hours
  • Bronchopleural fistula
  • Bridge to lung transplant
  • Recent lung transplantation (within previous 6 weeks)
  • Attending physician deems the transient application of high airway pressures (\>40 cm H2O) to be unsafe

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Health Network

Toronto, Ontario, M5G 2N2, Canada

Location

Related Publications (1)

  • Santa Cruz R, Villarejo F, Irrazabal C, Ciapponi A. High versus low positive end-expiratory pressure (PEEP) levels for mechanically ventilated adult patients with acute lung injury and acute respiratory distress syndrome. Cochrane Database Syst Rev. 2021 Mar 30;3(3):CD009098. doi: 10.1002/14651858.CD009098.pub3.

MeSH Terms

Conditions

Respiratory Distress SyndromeRespiratory Insufficiency

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract DiseasesRespiration Disorders

Study Officials

  • Ewan Goligher, MD, PhD

    University Health Network, Toronto

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 6, 2018

First Posted

July 18, 2018

Study Start

March 1, 2019

Primary Completion

March 31, 2021

Study Completion

August 31, 2021

Last Updated

November 21, 2023

Record last verified: 2020-08

Data Sharing

IPD Sharing
Will not share

Locations